Painless gastroscopy
Conditions
Interventions
Experimental group:Propofol at 2 mg/kg, with an initial dose of Nalbuphine at 0.1 mg/kg, adjusted in increments of 0.01 mg/kg using the Dixon up-and-down method
Sponsors
The Third People's Hospital of Hefei City
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients scheduled for painless gastrointestinal endoscopy, aged 18-65 years, with a BMI of 18-28 kg/m^2, and ASA physical status I-II.
Exclusion criteria
Exclusion criteria: Allergy to nalbuphine or propofol; liver or kidney dysfunction; history of neurologic, respiratory or cardiovascular disorders; psychiatric illness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dose of nalbuphine(mg);Total dose of propofol(mg);Ramsay Sedation Scale (RSS) score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Awakening time(s);Adverse events; | — |
Countries
China
Contacts
Public ContactJiang Meng
The Third People's Hospital of Hefei City
Outcome results
None listed